TMO
THERMO FISHER SCIENTIFIC INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$701.77
+0.49%Next report
Analyst consensus
- Next report date
- Feb 4, 2027
- EPS estimate
- $7.13
- Revenue estimate
- $12.9B
Latest reported
- Last report date
- Oct 21, 2026
- EPS actual
- $6.68
- EPS estimate
- $6.40
- Revenue actual
- $12.1B
- Revenue estimate
- $12.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +3.8%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $767
- PT range
- $730 – $810
- Analysts
- 9
8 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 21, 2026 | $6.40 | $6.68 | Beat 4.41% | $12.1B |
| Jul 23, 2026 | $5.72 | $6.03 | Beat 5.44% | $12.0B |
| Apr 23, 2026 | $5.25 | $5.44 | Beat 3.62% | $11.0B |
| Jan 29, 2026 | $6.45 | $6.57 | Beat 1.86% | $12.2B |
| Oct 22, 2025 | $5.50 | $5.79 | Beat 5.27% | $11.1B |
| Jul 23, 2025 | $5.23 | $5.36 | Beat 2.49% | $10.9B |
| Apr 23, 2025 | $5.10 | $5.15 | Beat 0.98% | $10.4B |
| Jan 30, 2025 | $5.94 | $6.10 | Beat 2.69% | $11.4B |
| Oct 23, 2024 | $5.25 | $5.28 | Beat 0.57% | $10.6B |
| Jul 24, 2024 | $5.12 | $5.37 | Beat 4.88% | $10.5B |
| Jan 31, 2024 | $5.64 | $5.67 | Beat 0.53% | $10.9B |
| Oct 25, 2023 | $5.61 | $5.69 | Beat 1.43% | $10.6B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 4, 2027